<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>"Metabolome" | Glembotski Lab</title><link>https://www.glembotskilab.org/tag/metabolome/</link><atom:link href="https://www.glembotskilab.org/tag/metabolome/index.xml" rel="self" type="application/rss+xml"/><description>"Metabolome"</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>© Glembotski Lab</copyright><lastBuildDate>Wed, 01 Jan 2014 00:00:00 +0000</lastBuildDate><image><url>https://www.glembotskilab.org/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png</url><title>"Metabolome"</title><link>https://www.glembotskilab.org/tag/metabolome/</link></image><item><title>PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity.</title><link>https://www.glembotskilab.org/publication/volkers-2014-emb-omolecularmedicine-6-57/</link><pubDate>Wed, 01 Jan 2014 00:00:00 +0000</pubDate><guid>https://www.glembotskilab.org/publication/volkers-2014-emb-omolecularmedicine-6-57/</guid><description/></item></channel></rss>